RECEPTOR ACTIVITY FOR POLYMERISED HUMAN ALBUMIN IN HEPATITIS B VACCINE
- 29 June 1985
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 325 (8444) , 1515-1516
- https://doi.org/10.1016/s0140-6736(85)92302-5
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Protection against hepatitis B virus infection by immunization with hepatitis B core antigenGastroenterology, 1985
- Binding activity of HBsAg particles from chronic HBsAg carriers to polystyrene beads coated with polymerized human serum albumin: diagnostic relevance of the assayLiver International, 1984
- An Antibody Which Precipitates Dane Particles in Acute Hepatitis Type B: Relation to Receptor Sites Which Bind Polymerized Human Serum Albumin on Virus ParticlesHepatology, 1984
- SUSCEPTIBILITY TO HEPATITIS B DESPITE HIGH TITRE ANTI-HBs ANTIBODYThe Lancet, 1984
- Failure of preexisting antibody against hepatitis B surface antigen to prevent subsequent hepatitis B infectionJournal of Clinical Microbiology, 1983
- A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final reportHepatology, 1981